Psilocybin therapy for PTSD relies heavily on silence, with patients speaking less during dosing than in preparation or integration sessions

Psilocybin-assisted therapy for PTSD appears to unfold largely in silence during the dosing session, with participants speaking far less than they do in preparation or integration. Verbal interaction drops sharply once the acute psychedelic effects begin, suggesting that inward attention rather than extended dialogue dominates the central therapeutic period. Session analyses indicate that talk time is concentrated before and after dosing, when therapists help establish safety, process difficult material, and integrate insights. The dosing phase itself seems to emphasize music, internal experience, and nonverbal support instead of continuous conversation. These patterns matter for clinical protocol design, therapist training, and expectations about how psychedelic therapy works in practice. PTSD treatment with psilocybin may depend not only on what is said, but on how carefully silence, presence, and timing are used across the full course of care.